409
Views
12
CrossRef citations to date
0
Altmetric
Review

Recent advances in the management of pancreatic adenocarcinoma

, &
Pages 51-62 | Received 07 May 2017, Accepted 07 Nov 2017, Published online: 13 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lei Zhang, Zhenyong Wang, Deshuai Kong, Xiulei Zhao, Xiongfei Chen & Wei Chai. (2020) Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells. Bioscience, Biotechnology, and Biochemistry 84:8, pages 1603-1613.
Read now

Articles from other publishers (11)

Ni Xie, Xuhui Fan, Desheng Chen, Jingwen Chen, Hongwei Yu, Meijuan He, Hao Liu, Xiaorui Yin, Baiwen Li & Han Wang. (2022) Peritumoral and Intratumoral Texture Features Based on Multiparametric MRI and Multiple Machine Learning Methods to Preoperatively Evaluate the Pathological Outcomes of Pancreatic Cancer . Journal of Magnetic Resonance Imaging 58:2, pages 379-391.
Crossref
Hwaida M. Mokhtar, Amira Youssef, Tamer M. Naguib, Amr A. Magdy, Samir A. Salama, Ahmed M. Kabel & Nesreen M. Sabry. (2022) The Significance of FDG PET/CT–Derived Parameters in Determining Prognosis of Cases with Pancreatic Adenocarcinoma: A Prospective Study. Medicina 58:8, pages 1027.
Crossref
Chen Ke, Liu Yuan, Yang Xiujiang & Shen Danjie. (2021) Integrated analysis of metabolome in a EUS-FNA sample with transcriptome in the TCGA cohort of pancreatic head and body/tail adenocarcinoma. Aging 13:6, pages 8880-8894.
Crossref
Valerie Jentzsch, James Davis & Mustafa Djamgoz. (2020) Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers 12:11, pages 3096.
Crossref
Bailu Xie, Jan Hänsel, Vanessa Mundorf, Janina Betz, Irene Reimche, Mert Erkan, Ibrahim Büdeyri, Anne Gesell, Russell G. Kerr, Ni Putu Ariantari, Haiqian Yu, Peter Proksch, Nicole Teusch & Randall J. Mrsny. (2020) Pseudopterosin and O-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal Adenocarcinoma. Bioengineering 7:2, pages 57.
Crossref
M. Abdel Kader, H. R. Abass & M. M. Suliman. (2019) Apparent diffusion coefficient of pancreatic adenocarcinoma: is there any congruity with tumor resectability?. Egyptian Journal of Radiology and Nuclear Medicine 50:1.
Crossref
Ke Chen, Yiping He, Yuan Liu & Xiujiang Yang. (2019) Gene signature associated with neuro‐endocrine activity predicting prognosis of pancreatic carcinoma. Molecular Genetics & Genomic Medicine 7:7.
Crossref
Junjie Piao, Lianhua Zhu, Jie Sun, Nan Li, Bing Dong, Yang Yang & Liyan Chen. (2019) High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. Gene 701, pages 15-22.
Crossref
Jazan Omari, Constanze Heinze, Antje Wilck, Peter Hass, Max Seidensticker, Ricarda Seidensticker, Konrad Mohnike, Jens Ricke, Maciej Pech & Maciej Powerski. (2019) Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas. European Journal of Radiology 112, pages 22-27.
Crossref
Chang-Il Kwon. (2019) Relief of Obstruction in the Management of Pancreatic Cancer. The Korean Journal of Gastroenterology 74:2, pages 69.
Crossref
Osman Ahmed & Jeffrey H. Lee. (2018) Preoperative biliary drainage for pancreatic cancer. International Journal of Gastrointestinal Intervention 7:2, pages 67-73.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.